Biodistribution of [64Cu]Cu2+ and variance of metallothionein during tumor treatment by copper

Nuclear Medicine and Biology

Volumn 25, Issue 2, 1998, Pages 111-116

  Yu, Meixiang ^a,d   Qing, Huai ^a   Guojian, Huang ^b   Shu, Zhou ^b   Wenqing, Wang ^a   Youfeng, He ^c   Kuikka, Jyrki T ^d  

^a PEKING UNIVERSITY   (China)

^b Clin Res Inst Chinese Japan F   (China)

^c CHINA INSTITUTE OF ATOMIC ENERGY   (China)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Copper; Free radical; Kinetic distribution; Metallothionein; Tumor

Indexed keywords

COPPER 64; FREE RADICAL; METALLOTHIONEIN; RADIOPHARMACEUTICAL AGENT; CADMIUM; COPPER; DIAGNOSTIC AGENT; SILVER; ZINC;

ANIMAL MODEL; ARTICLE; ASCITES TUMOR; CANCER RADIOTHERAPY; CONTROLLED STUDY; COPPER METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KINETICS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SOLID TUMOR; TISSUE DISTRIBUTION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; LIVER; LIVER TUMOR; METABOLISM; PHYSIOLOGY;

ANIMALS; CADMIUM RADIOISOTOPES; COPPER; COPPER RADIOISOTOPES; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METALLOTHIONEIN; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SILVER; TISSUE DISTRIBUTION; ZINC;

EID: 0031594522     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00169-8     Document Type: Article

References (55)

1. Agarwal K., Sharma A., Talukder G. Effects of copper on mammalian cell components. Chem. Biol. Interact. 69:1989;1-16.
2. Bremner I., Young B. Isolation of (copper, zinc)-thioneins from the livers of copper-injected rats. Biochem. J. 157:1976;517-520.
3. Cai L., Koropatnick J., Cherian M. G. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. Chem. Biol. Interact. 96:1995;143-155.
4. 64copper in the blood and different tissues of mice bearing induced fibrosarcoma. Neoplasma. 32:1985;553-559.
5. Crispens C. G., Sorenson J. R. Evaluation of combinations of Cu-DIPS, Tween 80 and cyclophosphamide as therapy for reticulum cell sarcoma in SJL/L mice. Anticancer Res. 9:1989;357-359.
6. 2+ transport and accumulation by hepatocytes from copper-deficient mice and the brindled mouse model of Menkes' disease. J. Biol. Chem. 258:1983;13621-13626.
7. Eaton D. L., Cherian M. G. Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol. 205:1992;83-88.
8. de Mello Filho A. C., Meneghini R. Protection of mammalian cells by o-phenanthrolene from lethal and DNA-damaging effects produced by active oxygen species. Biochim. Biophys. Acta. 847:1985;82-89.
9. Ebadi M., Swanson S. The status of zinc, copper, and metallothionein in cancer patients. Protein Clin. Biol. Res. 259:1988;161-175.
10. El-Ahmady O., El-Maraghy A., Ibrahim A., Ramzy S. Serum copper, zinc, and iron in patients with malignant and benign pulmonary diseases. Nutrition. 11(suppl):1995;498-501.
11. Fabris C., Farini R., Del Favero G., Gurrieri G., Piccoli A., Sturniolo G. C., Panucci A., Naccarato R. Copper, zinc and copper/zinc ratio in chronic pancreatitis and pancreatic cancer. Clin. Biochem. 18:1985;373-375.
12. Fare G., Howell J. S. The effect of dietary copper on rat carcinogenesis by 3-methoxy dyes I. Tumors induced at various sites by feeding 3-methoxy-4-aminoazobenzene and its N-methyl derivative . Cancer Res. 24:1964;1279-1283.
13. Fare G., Woodhouse D. L. The effect of copper acetate on biochemical changes induced in the rat liver by P-dimethylaminoazobenzene. Br. J. Cancer. 17:1963;512-523.
14. Gregoriadis G., Sourkes T. Intracellular distribution of copper in the liver of the rat. Can. J. Biochem. 45:1967;1841-1851.
15. Gupta S. K., Shukla V. K., Vaidya M. P., Roy S. K., Gupta S. Serum trace elements and Cu/Zn ratio in breast cancer patients. J. Surg. Oncol. 46:1991;178-181.
16. Haratake J., Horie A., Nakashima A., Takeda S., Mori A. Minute hepatoma with excessive copper accumulation Report of two cases with resection . Arch. Pathol. Lab. Med. 110:1986;192-194.
17. Hart B. A., Voss G. W., Vacek P. M. Metallothionein in human lung carcinoma. Cancer Lett. 75:1993;121-128.
18. Haywood S., Michael L., Roger M. B. Copper toxicosis and tolerance in the rat Intracellular localization of copper in the liver and kidney . Exp. Mol. Pathol. 43:1985;209-219.
19. Inutsuka S., Araki S. Plasma copper and zinc levels in patients with malignant tumors of digestive organs Clinical evaluation of the Cu/Zn ratio . Cancer. 42:1978;626-631.
20. Jendryczko A., Drozdz M., Tomala J., Magner K. Copper and zinc concentrations and superoxide dismutase activities in malignant and nonmalinant tissues of female reproductive organs. Neoplasma. 33:1986;239-244.
21. Freedman J. H., Peisach J. Resistance of cultured hepatoma cells to copper toxicity, purification and characterization of the hepatoma metallothionein. Biochim. Biophys. Acta. 992:1989;145-154.
22. Kloth D. M., Chin J. L., Cherian M. G. Induction of hepatic metallothionein I in tumor-bearing mice. Br. J. Cancer. 71:1995;712-716.
23. Kobayashi S., Sayato-Suzuki J. Zinc and copper accumulation and isometallothionein induction in mouse ascites sarcoma S180A cells. Biochem J. 249:1988;69-75.
24. Lesko S. A., Lorentzen R. J., Ts'o P. O. Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry. 19:1980;3023-3028.
25. Luza S. C., Speisky H. C. Liver copper storage and transport during development Implications for cytotoxicity . Am. J. Clin. Nutr. 63:1996;812S-820S.
26. Mattes W. B., Hartley J. A., Kohn K. W. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucl. Acids Res. 14:1986;2971-2987.
27. Mehra R. K., Bremner I. Species differences in the occurrence of copper metallothionein in the particulate fractions of the liver of copper-loaded animals. Biochem. J. 219:1984;539-546.
28. Minkel D. T., Poulsen K., Weilgus S., et al. On the sensitivity of metallothioneins to oxidation during isolation. Biochem. J. 191:1980;475-485.
29. Mistilis S. P., Farrer P. A. The absorption of biliary and non-biliary radiocopper in the rat. Scand. J. Gastroenterol. 3:1968;586-592.
30. Nayak K. K., Maity P., Bhattacharyya R. Antitumor activities of copper-ATP complex on transplantable murine lymphoma. Pharmacology. 4:1990;350-356.
31. Olivares M., Uauy R. Copper as an essential nutrient. Am. J. Clin. Nutr. 63:1996;791S-796S.
32. Olivares M., Uauy R. Limits of metabolic tolerance to copper and biological basis for present recommendations and regulations. Am. J. Clin. Nutr. 63:1996;846S-852S.
33. Oyama T., Matsuno K., Kawamoto T., Mitsudomi T., Shirakusa T., Kodama Y. Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer. Biol. Trace Elem. Res. 42:1994;115-127.
34. Pedrero E., Kozelka F. L. Effect of copper on hepatic tumors produced by 3′-methyl-4-dimethylaminoazobenzene. AMA Arch. Pathol. 52:1951;455-457.
35. Sakurai H., Satoh H., Hatanaka A., Sawada T., Hagino T., Nakajima K. Unusual generation of hydroxyl radicals in hepatic copper-metallothionein of LEC (Long-Evans cinnamon) rats in the presence of hydrogen peroxide. Biochem. Biophys. Res. Commun. 199:1994;313-318.
36. Satoh M., Miura N., Naganuma A., et al. Prevention of adverse effects of gamma-ray irradiation after metallothionein induction by bismuth subnitrate in mice. Eur. J. Cancer Clin. Oncol. 25:1989;1727-1731.
37. Sawaki M., Enomoto K., Hattori A., Tsuzuki N., Sugawara N., Mori M. Role of copper accumulation and metallothionein induction in spontaneous liver cancer development in LEC rats. Carcinogenesis. 15:1994;1833-1837.
38. Schaffner F., Sternlieb I., Barka T. Hepatocellular changes in Wilson's disease Histochemical and electron microscopic studies . Am. J. Pathol. 41:1962;315-328.
39. Scheinberg I. H., Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am. J. Clin. Nutr. 63:1996;842S-845S.
40. Scheuhammer A. M., Cherian M. G. Quantification of metallothionein by silver saturation. Methods Enzymol. 205:1992;78-83.
41. Sokol R. J., Devereaux M., Mierau G. W., Hambidge K. M., Shikes R. H. Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload Modification by vitamin E deficiency . Gastroenterology. 99:1990;1061-1071.
42. Sone T., Yamaoka K., Minami Y., et al. Induction of metallothionein synthesis in Menkes' and normal lymphoblastoid cells is controlled by the level of intracellular copper. J. Biol. Chem. 262:1987;5878-5885.
43. 64Cu . Clin. Sci. 43:1972;617-625.
44. Sugawara N., Sugawara C., Katakura M., et al. Copper metabolism in the LEC rat Involvement of metallothionein and disposition of zinc and iron . Experientia. 47:1991;1061-1063.
45. Suzuki K. T., Kanno S., Misawa S., Aoki Y. Copper metabolism leading to and following cute hepatitis in LEC rats. Toxicology. 97:1995;81-92.
46. Suzuki K. T., Karasawa A., Sunaga H., Kodama H., Yamanaka K. Uptake of copper from the bloodstream and its relation to induction of metallothionein synthesis in the rat. Comp. Biochem. Physiol. C. 94:1989;93-97.
47. Suzuki K. T., Rui M., Ueda J., Ozawa T. Production of hydroxyl radicals by copper-containing metallothionein Role as prooxidant . Toxicol. Appl. Pharmacol. 141:1996;231-237.
48. Syrkin A. B., Chlenova E. L. Antidotal and antineoplastic properties of copper sulfate. Bull. Exp. Biol. Med. 105:1988;477-479.
49. Thornalley P. J., Vasak M. Possible role for metallothionein in protection against radiation-induced oxidation stress Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals . Biochim. Biophys. Acta. 827:1985;36-44.
50. Toke G. B., Dhamne B. K. A study of serum copper, serum zinc and Cu/Zn ratio as diagnostic and prognostic index in cases of head, neck and face tumors. Indian J. Pathol. Microbiol. 33:1990;171-174.
51. 2+ compounds with alpha-amino acids. Bull. Exp. Biol. Med. 99:1985;86-88.
52. Yang M. H., Schaich K. M. Factors affecting DNA damage caused by lipid hydroperoxides and aldehydes. Free Rad. Biol. Med. 20:1996;225-236.
53. Yaucel I., Arpaci F., Ozet A., D'Aoner B., Karayilano-Åglu T., Sayar A., Berk O. Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer. Biol. Trace Elem. Res. 40:1994;31-38.
54. Yoshida D., Ikeda Y., Nakazawa S. Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors. J. Neurooncol. 16:1993;109-115.
55. Yoshiguki K., Sachio M., Sugihara S. The inhibitory effect of copper on DL-ethionine carcinogenesis in rats. Cancer Res. 33:1973;1129-1135.